Ernexa Therapeutics (ERNAW) Shares Issued (2010 - 2026)

Ernexa Therapeutics has reported Shares Issued for 12 years, with the latest figure at $10.5 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued rose 261900.0% year-over-year to $10.5 million; the trailing twelve-month figure through Mar 2026 stood at $10.5 million (up 851.63% YoY), and the FY2025 full-year result was $30000.0, down 97.36% from the prior year.
• Shares Issued for Q1 2026 stood at $10.5 million, up from -$4.9 million in the prior quarter.
• The five-year high for Shares Issued was $12.0 million in Q1 2022, with the low at -$4.9 million in Q3 2025.
• Historically, Shares Issued has averaged $4.5 million across 4 years, with a median of $4.9 million in 2025.
• Annual changes were most pronounced in 2025 — Shares Issued tumbled 545.36% — and 2026, when it soared 261900.0%.
• Ernexa Therapeutics' Shares Issued stood at $7.7 million in 2022, then slumped by 85.74% to $1.1 million in 2024, then plunged by 545.36% to -$4.9 million in 2025, then soared by 313.92% to $10.5 million in 2026.
• The last three Shares Issued figures came in at $10.5 million (Q1 2026), -$4.9 million (Q3 2025), and $4.9 million (Q2 2025), per Business Quant data.